Listing Id: 30757
Last Refreshed: 11/11/2024
Total Views: 526
(On Hold)Investors for NEW Probiotic & Postbiotic products
Ang Mo KioBiomedical ManufacturersFood Manufacturers
Asking Price: Price On Request
Business For Takeover
Look For Investor
Look For Partner
- Overview
- Reason For Sale
- Description
- Business Operation
Overview
-
Premise Type
Factory
-
Premise Size
1787 sqft / 166 sqm
-
Monthly Rental
N/A
-
Rental Desposit
N/A
-
Revenue
N/A
-
Liability
N/A
-
Gross Profit
N/A
-
Net Profit
N/A
-
Stock
N/A
-
FFE
N/A
-
Payable
N/A
-
Receivable
N/A
-
Owner Role
Full Time
-
Staff
2
-
Established
2022
-
Source
Direct Seller
Description
We are introducing a new line of premium probiotics and postbiotics made in Singapore, designed to support the health and well-being of all age groups, from children to adults and the elderly. We are seeking a total investment of $500,000, with each $100,000 investment securing a 10% equity stake. Investors will benefit from annual dividends, while operations and strategic decisions will remain fully under our management.
Our vision is to build a strong, reputable brand recognized for its quality and efficacy, with a key focus on establishing partnerships with hospitals and clinics in Singapore to offer these health-boosting products directly to patients. Alongside traditional distribution, we will launch our own website, invest in a dedicated team to conduct engaging, live sales sessions on TikTok, and expand our reach into promising markets in Indonesia and Thailand.
This is an exciting opportunity to join us in a fast-growing health sector with high potential returns, supported by our commitment to product excellence, innovative marketing strategies, and a clear path to regional expansion.
Business Operation
Lab machineries
Facilities
Overseas competitors
Competition
The global probiotic and postbiotic markets are experiencing rapid growth, driven by rising consumer interest in gut health and wellness. In 2023, the probiotic market was valued at about $63 billion and is projected to reach over $109 billion by 2030, with a compound annual growth rate (CAGR) of around 8% during this period. Demand is particularly strong in the Asia-Pacific region, where awareness of the gut microbiome’s impact on health and an aging population contribute significantly to growth.
The postbiotic market, although newer, is also expanding quickly due to its unique benefits for gut health and immunity. As of 2024, the postbiotic supplements market is forecasted to grow significantly, especially in regions like Japan and India, where consumer interest in organic and functional health products is increasing. In India, for example, the postbiotic market is expected to grow at a CAGR of 14.8% through 2034.
This growth in both markets reflects a global shift towards preventive health and dietary supplements, creating ample opportunity for brands focused on innovative, science-backed probiotic and postbiotic products.
Expansion Potential
Singapore